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Cellular stressLittle is known about either the basal or stimulated homeostatic mechanisms regulating nuclear tenure of
Nf-e2-related factor 2 (Nrf2), a transcription factor that mediates expression of over 200 detoxiﬁcation genes.
Our data show that stress-induced nuclear Nrf2 accumulation is largely from de novo protein synthesis,
rather than translocation from a pre-existing cytoplasmic pool. HepG2 cells were used to monitor nuclear
Nrf2 24 h following treatment with the dithiol micronutrient (R)-α-lipoic acid (LA; 50 μM), or vehicle. LA
caused a ≥2.5-fold increase in nuclear Nrf2 within 1 h. However, pretreating cells with cycloheximide
(50 μg/ml) inhibited LA-induced Nrf2 nuclear accumulation by 94%. Providing cells with the mTOR inhibitor,
rapamycin, decreased basal Nrf2 levels by 84% after 4 h, but LA overcame this inhibition. LA-mediated de
novo protein translation was conﬁrmed using HepG2 cells transfected with a bicistronic construct containing
an internal ribosome entry sequence (IRES) for Nrf2, with signiﬁcant (Pb0.05) increase in IRES use under LA
treatment. These results suggest that a dithiol stimulus mediates Nrf2 nuclear tenure via cap-independent
protein translation. Thus, translational control of Nrf2 synthesis, rather than reliance solely on pre-existing
protein, may mediate the rapid burst of Nrf2 nuclear accumulation following stress stimuli.
© 2012 Published by Elsevier B.V.1. Introduction
Nf-e2-related factor 2 (Nrf2) is a transcription factor that regulates
the expression ofmultiple Phase II detoxiﬁcation and antioxidant genes,
and is thus critical for cellular stress response [1].While theNrf2 gene is
constitutively expressed and the protein contains a nuclear localization
sequence [2], very little Nrf2 is typically found in the cell under
quiescent conditions. The mechanism associated with Nrf2 nuclear
accumulation under both quiescent and stress-induced conditions is
complex and only currently being elucidated. It is thought that
oxidation of or electrophilic addition to critical sulfhydryls on Keap1, a
Kelch-like actin-binding protein that bridges Nrf2 to the Cul3 E3
ubiquitin ligase [3,4], may prevent Nrf2 association or else causes its
release from the Keap1 complex [5–7]. Either scenario increases Nrf2
half-life [8], which allows for enhanced nuclear accumulation and
expression of stress response genes [9], including NAD(P)H quinone
oxidoreductase-1 (nqo1), heme oxygenase-1 (ho1), and those associ-
ated with glutathione (GSH) synthesis (both the catalytic [gclc] and
modulatory [gclm] subunits of glutamate-cysteine ligase, and glutathi-
one synthetase). Indeed, Keap1 knockout mice demonstrate theState University, Corvallis, OR
737 5077.
agen).
sevier B.V.importance of Keap1, as tissue from these animals exhibits constant
and excessive nuclear Nrf2 even during times of quiescence, and the
result is lethal [10].
In addition to Nrf2 regulation via Keap1 thiol redox control, previous
studies revealed that protein kinase C (PKC)-induced Nrf2 phosphor-
ylation at Ser40 causes its disassociation from Keap1 [11,12], indicating
that kinase-dependent stress signaling may regulate Nrf2 by discour-
aging Keap1-mediated degradation. However, it is not clear whether
Nrf2 phosphorylation affects its nuclear accumulation [11]. Thus, Nrf2
activation may be subject to numerous redox and signal transduction-
associated stimuli to elicit Nrf2 nuclear accumulation and induction of
stress response genes.
Despite this evidence, it is difﬁcult to understand how Keap1
redox interactions and/or Nrf2 phosphorylation solely are responsible
for enhanced Nrf2 nuclear tenure following a stimulus. Cellular Nrf2
levels are generally quite low under basal conditions, making it
difﬁcult to account for the large and rapid stress-induced increases in
nuclear Nrf2 ostensibly coming from an existing pool of Keap1-
tethered Nrf2. More speciﬁcally, Eggler et al. found that mutation of
critical cysteine residues was insufﬁcient to release Nrf2 from Keap1
[13], therefore calling into question the exclusive redox-dependent
nature of the Keap1/Nrf2 complex. The question remains whether
other potentially signiﬁcant pathways are involved in enhancing
nuclear Nrf2 levels after a stimulus. In this regard, the recent work by
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mRNA has an internal ribosome entry sequence (IRES) [14], suggest-
ing that Nrf2 translation would continue even under high stress
insults that typically halt global translation. IRESs are present in genes
vital for stress response and survival, and they allow the translational
machinery to bypass the 7-methyl-guanosine cap at the 5′ end of
mRNAs by providing an internal site for ribosomal binding, which is
known as “cap-independent translation.” Previous research on Nrf2
nuclear accumulation has elucidated the mechanism of its proteaso-
mal degradation, but little is known about how Nrf2 translation is
regulated. Thus, the full mechanism involved in stress-mediated Nrf2
nuclear accumulation has yet to be divulged.
Because of these signiﬁcant gaps in knowledge, the current study
was undertaken to determine whether Nrf2 protein synthesis is part
of the stimulus-induced mechanism associated with nuclear Nrf2
accumulation. Using the HepG2 liver cell line, this report shows that
(R)-α-lipoic acid (LA), a dithiol redox-active compound known to
induce Phase II detoxiﬁcation enzymes in an Nrf2-dependent manner,
elicits nuclear accumulation of Nrf2 by 1) increasing the half-life of
Nrf2 protein and 2) markedly enhancing translation of Nrf2 from
its existing hepatic mRNA pools. Synthesis of Nrf2 protein at the
basal level was blocked by rapamycin, an inhibitor of cap-dependent
translational initiation, but LA-induced Nrf2 synthesis was rapamycin-
independent. Use of a bicistronic construct containing the IRES of Nrf2
conﬁrmed that LA was able to activate cap-independent translation of
Nrf2. These results thus represent a novel and potentially signiﬁcant
addition to the existing knowledge of how Nrf2 functions to meet
environmental challenges.
2. Materials and methods
2.1. Cell culture
Cell culture-approved chemicals were obtained from Sigma-
Aldrich (St. Louis, MO, USA) except where noted. The human hepatic
carcinoma cell line, HepG2, was maintained with EMEM (ATCC), 10%
FBS, 2 mM L-glutamine, and antibiotics. Cells were maintained in a
37 °C incubatorwith 5% CO2.Mediawas changed at the end of each day,
at least 12 h before an experiment, to eliminate artifactual stimulation
from fresh media components.
2.2. Chemical treatments
(R)-α-lipoic acid was obtained fromMAKWood, Inc. (Grafton, WI,
USA). A 50 mM solution was made in dimethyl formamide (DMF)
vehicle, and LA was added to cell culture media at 1:1000 for a
concentration of 50 μM. Cycloheximide (CHX) was solubilized in DMF
and used at 50 μg/ml. Rapamycin (Calbiochem, IC50=50 pM) was
used to inhibit mTOR complex 1 (mTORC1) and was supplied at
10 nM ﬁnal concentration to cells at least 2 h prior to LA treatment.
Vehicle treatments were used as controls. PS341 (bortezomib), a
boronic acid that acts as a very potent proteasome inhibitor [15], was
a gift of Millennium Pharmaceuticals (Cambridge, MA, USA) and was
solubilized in DMF and provided to cells at 50 nM ﬁnal concentration.
2.3. Whole cell lysates and nuclear extracts
For whole cell lysates, cells were harvested by scraping, washed in
phosphate buffered saline (PBS), and sonicated in TNSEV buffer
(50 mM Tris, pH 7.5, 1% NP-40 (v/v), 100 mM NaCl, 2 mM EDTA,
2 mM sodium orthovanadate) containing protease and phosphatase
inhibitors. For nuclear extracts, cells were harvested, washed, and cell
pellets were allowed to swell for 15 min in Hypotonic Buffer (10 mM
HEPES, pH 7.9, 10 mMKCl, 1.5 mMMgCl2, plus freshly added protease
and phosphatase inhibitors). Plasma membranes were disrupted by
adding 0.6% (v/v) Igepal and vortexing, then nuclei were pelleted bycentrifugation at 12,000 rpm for 1 min at 4 °C. The cytosolic fraction
was removed and nuclei were washed and resuspended in the buffer
with Igepal. The method is described in detail in Shay et al. [16].
2.4. Immunoblotting
Lysates were prepared as described above, sonicated, and proteins
were solubilized for PAGE in Laemmli loading buffer containing SDS.
Sampleswere heat-denatured for 5 min at 100 °C. Normalized amounts
of protein (30 μg/lane) were run on SDS-PAGE and transferred to PVDF
membranes with a semi-dry blotter. Membranes were blocked in PBS
containing 1% Tween-20 with either 5% nonfat dry milk or 3% BSA,
incubated with primary antibodies for 2 h at room temperature,
washed, and incubated with secondary antibodies for 1 h at room
temperature, washed, incubatedwith chemiluminescence reagents, ex-
posed to ﬁlm, and developed. Antibodiesmade to the following proteins
were used: Nrf2 (H-300) and Keap1 (C-20) (Santa Cruz Biotech, USA),
4EBP1, Phospho-T-37/46-4EBP1, Lamin A/C, and LDHA (Cell Signaling
Technology, Beverly, MA, USA), and Actin (Sigma-Aldrich). The primary
antibodies were diluted in PBS-Tween for blotting. Blots were
densitometrically analyzed with ImageJ software from NIH.
2.5. RT-qPCR
For quantitative analysis of mRNA in cells, total RNA was isolated
from HepG2 cells using the RNAeasy Mini Kit (Qiagen, Valencia, CA,
USA). RNA (2 μg) was reverse transcribed using the RETROscript kit
(Ambion, Austin, TX, USA) and the provided polyadenylate primers.
TaqMan primers speciﬁc to NQO1, GCLC, NFE2L2 and β-actin were
obtained from Applied Biosystems (Austin, TX, USA). PCR ampliﬁca-
tion reactions were assembled using the TaqMan Gene Expression
Array Master Mix per the manufacturer's instructions. Reactions were
run on an MJ Research DNA Opticon 2 (Bio-Rad, Hercules, CA, USA)
for 40 cycles. Messenger RNA levels were estimated by the ΔΔCT
method (where CT is cycle threshold) from the β-actin internal
standard and are represented as percent change from untreated cells.
2.6. Transfection of bicistronic vector and measurement of luciferase
activity
A bicistronic vector containing human Nrf2's 5′ UTR and part of the
ORF (−83 through +45) in the intercistronic region was used as
described in Li et al. [14]. As a control to rule out ribosomal read
through, an additional vector with a hairpin structure upstream of
the Nrf2 5′ UTR was used, and cryptic promoter activity was also
ruled out [14]. HepG2 cells were transfected in 96-well plates using
Jet-PEI (Polyplus-transfection SA, Illkirch, France) according to the
manufacturer's instructions. The Dual-Luciferase Reporter Assay Sys-
tem (Promega, Madison,WI, USA)was used tomeasure the activities of
Renilla luciferase (Rluc) and ﬁreﬂy luciferase (Fluc). Eighteen hours
post-transfection, cells were washed in HBSS and lysed with 20 μl
passive lysis buffer. A SpectraMax L luminometer (Molecular Devices,
Sunnyvale, CA) was used to measure the Fluc and Rluc intensities.
To measure the Fluc activities, 20 μl lysate was mixed with 100 μl
Luciferase Assay Reagent II to generate a stabilized luminescent
signal. After the Fluc luminescence was quantiﬁed, the Fluc reaction
was quenched and the Rluc was simultaneously initiated by adding
100 μl Stop & Glo Reagent. Rluc/Fluc activities were normalized by
total protein concentration.
2.7. Statistics
Statistical analysis was performed with GraphPad Prism 5.0
software (GraphPad, San Diego, USA). At least 3 replicates were
performed for each experiment. Student's t-test, one-way ANOVA,
and two-way ANOVA were used to determine statistical signiﬁcance,
Fig. 1. Nrf2 enters the nucleus without a stimulus but has a short half-life. A) Cytoplasmic
and nuclear Nrf2 were assessed by Western blot using protein from HepG2 cells
incubated with 50 nM PS341 for the indicated times. Keap1 levels were also determined
byWestern blot under these conditions. Nrf2 graphs show themeans±SE of 3 experiments.
*Pb0.04, **Pb0.0002. B) RT-PCR analysis for gclc and nqo1 mRNA following PS341 time
course, N=5 for each. *Pb0.0001 vs. time 0. C) Cells were treated with 50 μg/ml
cycloheximide (CHX) for the indicated times. Nrf2 levels were determined by Western
blot and densitometry. Graph of nuclear Nrf2 shows the mean±SE of 3 experiments.
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signiﬁcant if the P value was b0.05.
3. Results
3.1. Nrf2 accumulates in both cytoplasmic and nuclear compartments
under proteasome inhibition
We used a relevant cell model for oxidative stress response and
detoxiﬁcation, the transformed hepatocyte cell line HepG2, to deﬁne the
characteristics of steady-state nuclear Nrf2 homeostasis during quies-
cence andunder stimulated conditions.While it is generally accepted that
Nrf2 responds to a variety stresses by accumulating in the nucleus,
relatively little is known about Nrf2 homeostasis under basal conditions,
except that it is subject to rapid proteasomal degradation [8,17,18]. We
therefore determined baseline Nrf2 turnover characteristics by treating
cells with PS341 or cycloheximide (CHX) to inhibit Nrf2 degradation or
synthesis, respectively. Treating cells for 4 hwith 50 nMPS341 resulted in
a 3- and 17-fold increase in cytoplasmic and nuclear Nrf2 levels, res-
pectively, relative to vehicle treatment (Fig. 1A). Keap1 is also subject to
proteasomal degradation, but 4 h PS341 did not produce a noticeable
increase in either cytoplasmic or nuclear Keap1 (Fig. 1A) under these
speciﬁc conditions. The enrichment in Nrf2 nuclear accumulation
suggests that no inducer of Nrf2 is necessary to initiate nuclear Nrf2
translocation, which corroborates the observation that Nrf2 has a cons-
titutively active nuclear localization signal [2]. Further, it is notable that
Nrf2 also accumulates in the cytoplasm when degradation is inhibited,
though the ways in which this pool differs from the nuclear pool remain
unknown. The nuclear Nrf2 that accumulates in the nucleus under PS341
is active, as evidenced by increased transcript proﬁles of gclc and nqo1,
two quintessential Nrf2-mediated Phase II detoxiﬁcation genes (Fig. 1B).
Vehicle-treated cells displayed very little Nrf2, so we sought to
determine the half-life of Nrf2 in our model. Monitoring the rate of Nrf2
loss over timeunder CHX treatment demonstrated that nuclearNrf2 has a
nominal half-life in HepG2 cells of ~12 min as shown in the graph in
Fig. 1C, which is in accordance with the whole-cell Nrf2 half-life in prev-
ious studies [8]. Cytoplasmic Nrf2 was below detection levels in the
accompanying Western blot. Based on these results using inhibitors of
protein synthesis and degradation, it appears that Nrf2 is continuously
produced and will spontaneously accumulate in the nucleus if it is not
degraded.
3.2. LA-mediated Nrf2 nuclear accumulation characteristics
For cell stimulation, we used LA, a dithiol compound that initiates
Nrf2-mediated expression of glutathione synthesizing genes [19,20]. A
low, physiological dose of LA (50 μM) [21] resulted in a 2.5-fold (Pb0.05)
increase in protein levels of Nrf2 in the nuclei of HepG2 cells within 1 h
after treatment (Fig. 2A). Nrf2 levels remained elevated even 24 h fol-
lowing LA treatment in HepG2 cells, but did not result in changes to
Nrf2 transcript levels up to 8 h after the stimulus relative to vehicle
treatment (Fig. 2B). This shows that LA elicits a rapid, sustained increase
in nuclear Nrf2 levels, which is not from an induction of Nrf2 gene
expression.
LA-induced nuclear Nrf2 accumulation was sufﬁcient to increase
transcript proﬁles of the Nrf2-regulated genes gclc and nqo1 (Fig. 2B),
showing that LA did indeed induce sufﬁcient Nrf2 to perform its
transcriptional function. Thus, conditions were deﬁned for both
steady-state nuclear homeostasis under both basal conditions and
stemming from a physiologically relevant stimulus.
3.3. LA-induced Nrf2 nuclear accumulation requires new protein synthesis
Next, we asked whether the Nrf2 protein found in the nucleus in
both quiescent and LA-stimulated conditions stemmed from alter-
ations in Nrf2 half-life (reﬂecting less interactionwith Keap1), newlytranslated protein, or both. For monitoring Nrf2 half-life under a
stimulus, cells were incubated with LA (50 μM) for 1 h prior to adding
CHX, after which samples were taken at the times indicated. Under
Fig. 2. LA stimulates nuclear accumulation of Nrf2 without changes in its mRNA.
A) HepG2 cells (N=3) were treated with 50 μM LA for up to 24 h prior to harvest. Nrf2
levels were determined by Western blot and densitometry. The graph of nuclear Nrf2
shows the mean±SE. *Pb0.05 vs. time 0. B) RT-PCR analysis for nrf2, gclc, and nqo1
mRNA following an LA time course, N=5 for each. *Pb0.05 vs. time 0.
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was more than 4 times longer than that observed under quiescent
conditions (see Fig. 1C); however, it must be noted that the prolonged
stimulus-induced T1/2 alone could not account for the sustained nuclear
Nrf2 tenure observed in Fig. 2A.
To determine whether the Nrf2 accumulation resulted from
sequestered cytoplasmic pools or from newly synthesized protein
stemming from the LA stimulus, CHX was added prior to LA
stimulation. If pre-existing Nrf2 translocates to the nucleus upon LA
treatment, there would be an elevation of nuclear Nrf2 levels
despite the addition of CHX. In contrast, results showed that no
Nrf2 accumulated in the nucleus (Fig. 3B) under CHX interdict
(Pb0.0001), nor was any increase in Nrf2 observed in the cytoplasm
after LA. Interestingly, an overall loss of nuclear Nrf2 is observed
under CHX vs. vehicle alone (Pb0.0001). This was likely because of
proteasomal degradation where basal levels of Nrf2 are being
degraded and are not being renewed. These results show that LA, in
addition to increasing nuclear Nrf2 half-life from ~12 to ~55 min, also
surprisingly induces new Nrf2 protein synthesis. Keap1, in contrast,
was not changed with LA treatment (Fig. 3B). To further examine
the implications of these results, the combination of proteasome
inhibition and LA stimulation was tested. When HepG2 cells were
treated with both LA and PS341, signiﬁcantly (Pb0.05) more Nrf2
nuclear accumulation occurred vs. either treatment alone (Fig. 3C),
conﬁrming that LA plays a dual role in increasing Nrf2 protein levels.
3.4. LA overcomes translational inhibition by rapamycin and induces use
of Nrf2's IRES
To further assess a potential LA-dependent translational mechanism,
we determined whether inhibiting mTORC1, the serine/threonine kinasethat mediates cap-dependent translation, modulates LA-stimulated
nuclear Nrf2 levels. Using the macrolide rapamycin to inhibit mTORC1,
we observed a steady decrease in whole-cell Nrf2 levels over time
(Fig. 4A). This indicates that Nrf2 translation in unstimulated cells,
Nrf2 translation is cap-dependent and regulated bymTORC1. However,
pretreating cells with rapamycin to inhibit mTORC1 did not prevent an
LA-induced Nrf2 protein increase (Fig. 4A), which shows that LA
overcomes mTORC1 inhibition to increase Nrf2 levels.
In light of these results and those showing that Nrf2 half-life was
lengthened following LA treatment (Fig. 3A), further experiments
were performed to determine whether the LA-induced Nrf2 seen
after pretreatment with rapamycin was pre-existing. Results showed
that adding CHX ﬁrst kept LA from overcoming rapamycin inhibition
(Fig. 4B). Thus, we conclude that LA-induced Nrf2 accumulation
largely resulted from newly synthesized Nrf2.
4EBP1 is a key protein for regulating cap-independent transla-
tion; when hypophosphorylated, it sequesters eIF4E from binding
to the 5′ cap of mRNAs. Thus, phosphorylation of 4EBP1 promotes
cap-dependent translation, while failure to phosphorylate it (as under
stress conditions) decreases global protein translation and only cap-
independent translation of stress-response and survival-related
proteins can proceed. As shown in Fig. 4A, within 2 h, rapamycin
reduced phosphorylation of T37/464EBP1 dramatically but not complete-
ly, which is in accordance with Yip et al. who state that this is a function
of mTOR's structure [22]. In spite of the continued presence of Nrf2
under rapamycin+LA, LA was not able to overcome rapamycin's
reduction of 4EBP1 phosphorylation (Fig. 4A), indicating that LA
does not promote cap-dependent translation of Nrf2 by facilitating
the re-phosphorylation of 4EBP1. LA alone caused no signiﬁcant change
in phospho-4EBP1 (Fig. 4C), and thus would not appear to affect the
amount of eIF4E available to bind the 5′ caps of mRNAs [23].
In the same time course of up to 4 h, LA stimulated nuclear
accumulation of Nrf2 even in the presence of rapamycin (Fig. 5A).
Although the results in Fig. 4 show that this is largely due to new Nrf2
protein synthesis and not solely reduced turnover, we sought to
separate these mechanisms. Because a recent report by Li et al. [14]
showed that Nrf2 has an IRES, we sought to determine whether this
IRES is utilized to maintain Nrf2 translation under LA treatment. For
this determination, HepG2 cells were transfected with a bicistronic
vector in which the 5′ UTR of wild type Nrf2 was subcloned into the
intercistronic region, resulting in the production of Fireﬂy Luciferase
when the IRES is used (Fig. 5B). Renilla Luciferase is produced in
response to cap-dependent translation. Transfected cells were treated
with rapamycin and/or LA in the same manner as performed in
Fig. 5A. LA treatment markedly stimulated appearance of Fireﬂy
Luciferase (Fig. 5C), which qualitatively suggests that LA's actions on
translation were mediated through the IRES of Nrf2. Interestingly,
there was a small but signiﬁcant (Pb0.05) decrease in Renilla
Luciferase under not only rapamycin, but also LA or the combination
of the two compounds. This suggests that both modes of translation
may operate, to some degree, depending on the stimulus. Fig. 5C
conﬁrms that the Nrf2 IRES is active in response to LA in spite of
the presence of rapamycin. These results further suggest that
LA-dependent translational changes to Nrf2 can occur even when
mTORC1 activity is impaired. Taken together, these data indicate that
LA promotes cap-independent translation of Nrf2.
4. Discussion
Herein, we describe a novel means of explaining a stimulus-
induced increase in Nrf2 levels that must be considered an addition to
the well-studied mechanism of Keap1/Nrf2 sequestration. In our
model, rather than a large pool of existing Nrf2 being translocated to
the nucleus upon LA treatment, the majority of Nrf2 was newly
synthesized via translational mechanisms, without a concomitant
increase in mRNA. This system of highly controlled protein synthesis
Fig. 3. Nuclear accumulation of Nrf2 under LA requires new protein synthesis. A) HepG2 cells were treated with 50 μg/ml CHX for the indicated times after preincubation for 1 h
with 50 μM LA. Nuclear extracts were separated by SDS-PAGE, transferred to membranes, and probed for Nrf2, Keap1, and loading controls. The graph shows the mean±SE of 3
experiments. B) Cells were treated with vehicle only, 50 μM LA for 1 h, or pretreated with 50 μg/ml CHX for 5 min before 1 h treatment with LA or additional vehicle. Cell extracts
were separated by SDS-PAGE, transferred to membranes, and probed for Nrf2. The graph of nuclear Nrf2 shows the mean±SE of 4 experiments. *Pb0.0001 vs. vehicle and †;
†Pb0.0001 vs. vehicle and *. C) Cells were preincubated with 50 nM PS341 for 1 h prior to a 4 h bolus of 50 μM LA or vehicle. Cell extracts were run on SDS-PAGE and Western
blotting was performed for Nrf2. The graph of nuclear Nrf2 shows the means±SE of 3 experiments. *Pb0.05 vs. vehicle and †; †Pb0.05 vs. vehicle and *.
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cell can induce Nrf2 translation upon receiving a stress signal without
having to induce transcription of Nrf2. Furthermore, Nrf2 can still be
synthesized by cap-independent translation if the mTORC1 system is
repressed. As a stimulus, LA also facilitates a lengthening of Nrf2 half-
life. Keap1, which is associated with Nrf2 degradation, is thought to
be the limiting factor in the Nrf2/Keap1 system [24,25], so a surfeit of
newly synthesized Nrf2 may overwhelm the ability of Keap1
molecules to bind it. In fact, our data show that nuclear Nrf2 half-
life increases to approximately 55 min after LA treatment (Fig. 3A),
which is notable, but is not long enough to account for Nrf2's
sustained nuclear tenure seen in Fig. 2A. Thus, our data point to a
translational control mechanism which should also be considered
when evaluating the effects of other compounds that stimulate Nrf2
nuclear accumulation.These ﬁndingsmust be placed in contextwith the known regulatory
mechanisms that affect steady-state levels of Nrf2 in the nucleus. Nrf2 is
constitutively expressed and its transcription is not affected by the
stressors or antioxidants that so affect its protein levels. However, Nrf2
protein is subject to continual degradation by the Keap1-Cul3 ubiquitin
ligase system, such that high amounts of cellular Nrf2 are not seen on a
basal level. Nrf2 has nuclear localization signals (NLS) aswell as nuclear
export signals (NES) [2,25–27]. Cells expressing an Nrf2 construct with
a mutated NES display nuclear localization of Nrf2 even in the absence
of a stimulus, while cells expressing an Nrf2 construct with a mutated
NLS cannot transport Nrf2 into the nucleus even under conditions that
induce nuclear accumulation of wild-type Nrf2 (i.e., 50 μM t-BHQ);
instead, Nrf2 with a mutated NLS remains cytoplasmic [2]. Under basal
conditions, most cells show both cytoplasmic and nuclear distribution
of exogenously expressed wild-type Nrf2 [26].
Fig. 4. LA overcomes translational inhibition of Nrf2 by rapamycin. A) Nrf2 was measured by Western blot in whole cell extracts from HepG2 cells treated with 10 nM rapamycin.
*Pb0.05 vs. time 0. B) Nrf2 in whole cell extracts from cells pretreated with 10 nM rapamycin and then given CHX (50 μg/ml) or vehicle before the addition of 50 μM LA. *Pb0.0015
vs. time 0. C) Phospho-4EBP1 and total 4EBP1 were measured by Western blot in cells treated up to 4 h with 50 μM LA, P>0.05. All graphs show the means±SE of 3 experiments.
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unfolded protein response [28], viral infection [29], and oxidative/
genotoxic stress (reviewed in [30]), which can beneﬁt from the
upregulation of genes encoding Phase II enzymes. We have also
shown that LA induces the nuclear accumulation of Nrf2 in rat liver
tissue and increases the transcription of ARE-containing, Nrf2-driven
genes [19]. As a dithiol electrophile, LA can be considered a typical
sulfhydryl inducer of Nrf2. In the event of a stress signal such as
treatment with LA, Nrf2 is localized in the nucleus. LA is a redox active
compound, and thiol modiﬁcation of Keap1 has been proposed as a
mechanism for catalyzing the release of Nrf2 [6]. However, the precise
mechanism(s) involved in Nrf2 nuclear tenure under a stimulus has not
been fully elucidated. Eggler et al. [13] and Hong et al. [31] haveproposed that thiol modiﬁcation of Keap1 switches ubiquitylation from
Nrf2 to Keap1, catalyzing not so much a “release” of Nrf2 as a lack of
available Keap1 to tether it. Certainly, our results show that LA-induced
nuclear accumulation of Nrf2 does not coincide with a rise in
cytoplasmic Nrf2, but with de novo synthesis of Nrf2. It is not known,
however, whether the thiol modiﬁcation of Keap1 is enough to allow
Nrf2 to localize to the nucleus. As Kobayashi et al. [7] found that
mutation of Keap1 cysteines 273 and 288 was insufﬁcient to cause Nrf2
release, although Nrf2 degradation was decreased and cytoplasmic
accumulationwas observed. In none of our experiments didwe observe
an LA-induced increase in cytoplasmic Nrf2. Further, the half-life of
nuclear Nrf2 increased to 55 min under LA stimulus (Fig. 3A), which is
still quite short. Jain and Jaiswal [32] showed that Nrf2 nuclear export is
Fig. 5. Nrf2 IRES is induced by LA during rapamycin treatment. A) HepG2 cells were
preincubated with vehicle or 10 nM rapamycin before a time course of 50 μM LA. Nrf2
protein was assessed by Western blot. B) Adapted from Li et al. [14]: wild-type 5′-UTR
of human Nrf2 mRNA was subcloned into the intercistronic region of a bicistronic
vector containing a Rluc and a Fluc. 5′-UTR: 5′-untranslated region; (A)n: poly(A) tail;
ORF: open reading frame. C) Cells were transfected with the bicistronic vector in which
the 5′ UTR of Nrf2 is accessed only via its IRES and Fireﬂy Luciferase (Fluc) activity
indicates cap-independent translation. Renilla Luciferase (Rluc) activity indicates cap-
dependent translation. Cells were treated as in (A) above, and dual luciferase activity
was monitored by photon counting on a SpectraMax luminescence plate reader. The
graphs show the means±SE of 3 experiments. *Pb0.05 compared to vehicle in Rluc
samples. †Pb0.05 compared to vehicle in Fluc samples.
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exported into the cytosol via its NES for Keap1-mediated degradation
[2]. Although Keap1 occurs in the nucleus of HepG2 and NIH3T3 cells
[33], where 26S proteasomes are also present [34], current evidence
suggests that Nrf2 degradation takes place only in the cytoplasmic
compartment [32,35]. Our results make sense in this context, as Nrf2
may have translocated to the cytoplasm for Keap1-mediated degrada-
tion, explaining both its relatively short (b1 h) half-life and its
cytoplasmic levels typically being below detection limits.
A recent paper by Sun et al. [36] implicates the protein KPNA6 in
the nuclear import of Keap1, thereby promoting the ubiquitination
and degradation of Nrf2 and “resetting” the basal levels of Nrf2.
Because of this, siRNA knockdown of KPNA6 increases nuclear Nrf2.
While we did not test the effect of LA on the levels of KPNA6 itself, we
did note that Keap1 half-life was not affected by LA treatment
(Supplemental Fig. 1A), nor did LA signiﬁcantly increase nuclear
levels of Keap1 (Supplemental Fig. 1B) at the dose and times
measured. More work will need to be done to determine the effect,
if any, of LA on KPNA6-mediated Keap1 import.
Examination of Nrf2 subcellular localization under proteasome
inhibition showed that Nrf2 levels build up in both cytoplasm andnucleus without any stimulus (Fig. 1A). The combination of PS341
and LA treatment increased Nrf2 levels in comparison to either
compound alone (Fig. 3C), conﬁrming that LA does not merely
prevent degradation of existing Nrf2, which is in accordance with
Nrf2 being newly translated in response to LA. This is interesting in
light of the important work done by Purdom-Dickinson et al., who
showed that H2O2 induces Nrf2 translation, but does not lengthen its
half-life [37]. LA, by contrast, does both. It is notable, however, that LA
results in sustained Nrf2 nuclear tenure for as long as 24 h in our
model (Fig. 2A), which cannot be explained solely by its increase in
half-life. Thus it appears that the majority of Nrf2 that accumulates in
the nucleus after LA treatment is newly translated.
Additionally, our data suggest that the mTORC1-mediated transla-
tional system is involved in Nrf2 steady-state levels (Figs. 4 and 5), but
inhibition of this complex by rapamycin cannot prevent translation
of Nrf2 under LA-induced stimulation. These results are signiﬁcant,
as mTORC1 is a major point of control for protein translation. In its
activated state, mTORC1 receives multiple input signals related to
energy status and cellular stress conditions [22]. Under permissive
conditions, this complex catalyzes phosphorylation of 4EBP1, a regulator
of cap-dependent protein translation, whereupon 4EBP1 is released
from eIF4E. Cap-dependent translation proceeds when unbound eIF4E
binds the 7mGpppN cap on the 5′ end of mRNAs, and eIF4G forms a
bridge between this factor and the 40S ribosomal subunit [38]. In the
event of no available eIF4E, cap-independent translation can still occur
in certain mRNAs via IRESs [38], which vary in their use of particular
initiation factors, but do not require eIF4E [39]. These sequences are
found in transcripts encoding proteins that are important for cell
stress response and survival, and a switch to conditions favoring cap-
independent translation results from various stress stimuli [40].
Kong and coworkers found that Nrf2 contains an IRES [14], which
further classiﬁes Nrf2 as a vital stress response gene. Our data ﬁt with
this interpretation as nuclear accumulation of Nrf2 resulted from an
alteration of the mTOR pathway by LA. When Kong's group used a
dual luciferase vector to measure the use of Nrf2's IRES, H2O2 induced
translation via both mechanisms, but sulforaphane primarily used the
IRES [14]. Our ﬁndings showed that usage of general cap-dependent
translation did not increase after LA treatment, but there was a marked
increase in cap-independent translation of Nrf2 via its IRES, asmeasured
by Fireﬂy Luciferase (Fig. 5C). A recent work by Zhang et al. [41] shows
that the Sjögren Syndrome Antigen B (SSB; also called La autoantigen)
protein binds to the 5′ UTR of Nrf2 and induces cap-independent
translation under H2O2 treatment. SSB colocalizes with ribosomes in a
redox-sensitive manner. While we did not test our samples for the
presence of this binding protein, it is quite possible that LA, as a redox-
active compound, could affect the localization of SSB to increase Nrf2
protein translation.
In summary, the LA-induced nuclear accumulation of Nrf2 via a
translational mechanism, rather than that of an existing pool of
cytoplasmic Nrf2, is a novel ﬁnding. The large amounts of Nrf2
observed in the nucleus after stress stimuli do not appear to correlate
with the cytoplasmic levels of Nrf2 held by Keap1, and indeed, as
posited by Pickett's group, constitutive synthesis of such a large pool
of Nrf2 only to degrade it immediately would represent an inefﬁcient
use of cellular energy [24]. Our data using LA provide evidence that
new protein synthesis, in addition to the inhibition of degradation, is
crucial to increasing the nuclear levels of Nrf2.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.bbamcr.2012.04.002.Acknowledgements
This work was supported by grants from the National Institutes of
Health R01 2AG17141 and P01 AT002034-01. KPS was supported by
T32 AT002688-01.
1109K.P. Shay et al. / Biochimica et Biophysica Acta 1823 (2012) 1102–1109References
[1] J.M. Lee, J.A. Johnson, An important role of Nrf2-ARE pathway in the cellular
defense mechanism, J. Biochem. Mol. Biol. 37 (2004) 139–143.
[2] A.K. Jain, D.A. Bloom, A.K. Jaiswal, Nuclear import and export signals in control of
Nrf2, J. Biol. Chem. 280 (2005) 29158–29168.
[3] S.B. Cullinan, J.D. Gordan, J. Jin, J.W. Harper, J.A. Diehl, The Keap1-BTB protein is an
adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a
Cul3-Keap1 ligase, Mol. Cell. Biol. 24 (2004) 8477–8486.
[4] A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, M.
Yamamoto, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based
E3 ligase to regulate proteasomal degradation of Nrf2, Mol. Cell. Biol. 24 (2004)
7130–7139.
[5] D.D. Zhang, M. Hannink, Distinct cysteine residues in Keap1 are required for
Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by
chemopreventive agents and oxidative stress, Mol. Cell. Biol. 23 (2003)
8137–8151.
[6] A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh,
M. Yamamoto, P. Talalay, Direct evidence that sulfhydryl groups of Keap1 are the
sensors regulating induction of phase 2 enzymes that protect against carcinogens
and oxidants, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11908–11913.
[7] A. Kobayashi, M.I. Kang, Y. Watai, K.I. Tong, T. Shibata, K. Uchida, M. Yamamoto,
Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiqui-
tination activity of Keap1, Mol. Cell. Biol. 26 (2006) 221–229.
[8] T. Nguyen, P.J. Sherratt, H.C. Huang, C.S. Yang, C.B. Pickett, Increased protein
stability as a mechanism that enhances Nrf2-mediated transcriptional activation
of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome,
J. Biol. Chem. 278 (2003) 4536–4541.
[9] A.K. Jaiswal, Nrf2 signaling in coordinated activation of antioxidant gene
expression, Free Radic. Biol. Med. 36 (2004) 1199–1207.
[10] N. Wakabayashi, K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, S. Takahashi, S.
Imakado, T. Kotsuji, F. Otsuka, D.R. Roop, T. Harada, J.D. Engel, M. Yamamoto,
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2
activation, Nat. Genet. 35 (2003) 238–245.
[11] D.A. Bloom, A.K. Jaiswal, Phosphorylation of Nrf2 at Ser40 by protein kinase C in
response to antioxidants leads to the release of Nrf2 from INrf2, but is not
required for Nrf2 stabilization/accumulation in the nucleus and transcriptional
activation of antioxidant response element-mediated NAD(P)H:quinone
oxidoreductase-1 gene expression, J. Biol. Chem. 278 (2003) 44675–44682.
[12] H.C. Huang, T. Nguyen, C.B. Pickett, Phosphorylation of Nrf2 at Ser-40 by protein
kinase C regulates antioxidant response element-mediated transcription, J. Biol.
Chem. 277 (2002) 42769–42774.
[13] A.L. Eggler, G. Liu, J.M. Pezzuto, R.B. van Breemen, A.D. Mesecar, Modifying
speciﬁc cysteines of the electrophile-sensing human Keap1 protein is insufﬁcient
to disrupt binding to the Nrf2 domain Neh2, Proc. Natl. Acad. Sci. U. S. A. 102
(2005) 10070–10075.
[14] W. Li, N. Thakor, E.Y. Xu, Y. Huang, C. Chen, R. Yu, M. Holcik, A.N. Kong, An internal
ribosomal entry site mediates redox-sensitive translation of Nrf2, Nucleic Acids
Res. 38 (2010) 778–788.
[15] J. Adams, M. Behnke, S. Chen, A.A. Cruickshank, L.R. Dick, L. Grenier, J.M. Klunder,
Y.T. Ma, L. Plamondon, R.L. Stein, Potent and selective inhibitors of the
proteasome: dipeptidyl boronic acids, Bioorg. Med. Chem. Lett. 8 (1998)
333–338.
[16] K.P. Shay, E.J. Smith, T.M. Hagen, Transcription factor Nrf2: examination of
nuclear protein levels by immunoblotting and promoter response element
binding by chromatin immunoprecipitation (ChIP), Curr. Protoc. Toxicol. 45
(2010) 17.13.1–17.13.13.
[17] K.R. Sekhar, X.X. Yan, M.L. Freeman, Nrf2 degradation by the ubiquitin
proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2,
Oncogene 21 (2002) 6829–6834.
[18] D. Stewart, E. Killeen, R. Naquin, S. Alam, J. Alam, Degradation of transcription
factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium,
J. Biol. Chem. 278 (2003) 2396–2402.
[19] J.H. Suh, S.V. Shenvi, B.M. Dixon, H. Liu, A.K. Jaiswal, R.M. Liu, T.M. Hagen, Decline
in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis,which is reversible with lipoic acid, Proc. Natl. Acad. Sci. U. S. A. 101 (2004)
3381–3386.
[20] R.M. Ogborne, S.A. Rushworth, M.A. O'Connell, Alpha-lipoic acid-induced heme
oxygenase-1 expression is mediated by nuclear factor erythroid 2-related factor 2
and p38 mitogen-activated protein kinase in human monocytic cells, Arterioscler.
Thromb. Vasc. Biol. 25 (2005) 2100–2105.
[21] K. Petersen Shay, R.F. Moreau, E.J. Smith, T.M. Hagen, Is alpha-lipoic acid a
scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress
signaling pathways that promote endogenous antioxidant capacity, IUBMB Life
60 (2008) 362–367.
[22] C.K. Yip, K. Murata, T. Walz, D.M. Sabatini, S.A. Kang, Structure of the human
mTOR complex I and its implications for rapamycin inhibition, Mol. Cell 38
(2010) 768–774.
[23] G.C. Scheper, B. van Kollenburg, J. Hu, Y. Luo, D.J. Goss, C.G. Proud, Phosphory-
lation of eukaryotic initiation factor 4E markedly reduces its afﬁnity for capped
mRNA, J. Biol. Chem. 277 (2002) 3303–3309.
[24] T. Nguyen, P. Nioi, C.B. Pickett, The Nrf2-antioxidant response element signaling
pathway and its activation by oxidative stress, J. Biol. Chem. 284 (2009)
13291–13295.
[25] W. Li, M.R. Jain, C. Chen, X. Yue, V. Hebbar, R. Zhou, A.N. Kong, Nrf2 Possesses a
redox-insensitive nuclear export signal overlapping with the leucine zipper
motif, J. Biol. Chem. 280 (2005) 28430–28438.
[26] W. Li, S.W. Yu, A.N. Kong, Nrf2 possesses a redox-sensitive nuclear exporting
signal in the Neh5 transactivation domain, J. Biol. Chem. 281 (2006)
27251–27263.
[27] M. Theodore, Y. Kawai, J. Yang, Y. Kleshchenko, S.P. Reddy, F. Villalta, I.J. Arinze,
Multiple nuclear localization signals function in the nuclear import of the
transcription factor Nrf2, J. Biol. Chem. 283 (2008) 8984–8994.
[28] S.B. Cullinan, D. Zhang, M. Hannink, E. Arvisais, R.J. Kaufman, J.A. Diehl, Nrf2 is a
direct PERK substrate and effector of PERK-dependent cell survival, Mol. Cell. Biol.
23 (2003) 7198–7209.
[29] D. Burdette, M. Olivarez, G. Waris, Activation of transcription factor Nrf2 by
hepatitis C virus induces the cell-survival pathway, J. Gen. Virol. 91 (2010)
681–690.
[30] W.O. Osburn, T.W. Kensler, Nrf2 signaling: an adaptive response pathway for
protection against environmental toxic insults, Mutat. Res. 659 (2008) 31–39.
[31] F. Hong, K.R. Sekhar, M.L. Freeman, D.C. Liebler, Speciﬁc patterns of electrophile
adduction trigger Keap1 ubiquitination and Nrf2 activation, J. Biol. Chem. 280
(2005) 31768–31775.
[32] A.K. Jain, A.K. Jaiswal, Phosphorylation of tyrosine 568 controls nuclear export of
Nrf2, J. Biol. Chem. 281 (2006) 12132–12142.
[33] M. Velichkova, T. Hasson, Keap1 regulates the oxidation-sensitive shuttling of
Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export
mechanism, Mol. Cell. Biol. 25 (2005) 4501–4513.
[34] J.M. Peters, W.W. Franke, J.A. Kleinschmidt, Distinct 19 S and 20 S subcomplexes
of the 26 S proteasome and their distribution in the nucleus and the cytoplasm, J.
Biol. Chem. 269 (1994) 7709–7718.
[35] Z. Sun, S. Zhang, J.Y. Chan, D.D. Zhang, Keap1 controls postinduction repression of
the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2, Mol.
Cell. Biol. 27 (2007) 6334–6349.
[36] Z. Sun, T. Wu, F. Zhao, A. Lau, C.M. Birch, D.D. Zhang, KPNA6 (Importin α7)-
mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant
response, Mol. Cell. Biol. 31 (2011) 1800–1811.
[37] S.E. Purdom-Dickinson, E.V. Sheveleva, H. Sun, Q.M. Chen, Translational control of
Nrf2 protein in activation of antioxidant response by oxidants, Mol. Pharmacol.
72 (2007) 1074–1081.
[38] M.W. Hentze, eIF4G: a multipurpose ribosome adapter? Science 275 (1997)
500–501.
[39] G. Hernandez, Was the initiation of translation in early eukaryotes IRES-driven?
Trends Biochem. Sci. 33 (2008) 58–64.
[40] M. Holcik, N. Sonenberg, R.G. Korneluk, Internal ribosome initiation of translation
and the control of cell death, Trends Genet. 16 (2000) 469–473.
[41] J. Zhang, T.N. Dinh, K. Kappeler, G. Tsaprailis, Q.M. Chen, La autoantigen mediates
oxidant induced de novo Nrf2 protein translation, Mol. Cell Proteomics (2011)
(Electronic publication ahead of print 2011).
